Sjögren's syndrome

Best Practice and Research: Clinical Rheumatology

Volumn 18, Issue 3, 2004, Pages 313-329

  Venables, Patrick J W ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Alpha interferon; Cemiveline; Hydroxychloroquine; Hypofunction; M3 antibodies; Pilocarpine; Sj gren's syndrome

Indexed keywords

ACETYLCYSTEINE; ALPHA INTERFERON; AZATHIOPRINE; B LYMPHOCYTE ANTIBODY; BIOXTRA; CARBOMER; CEVIMELINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOTOXIC AGENT; GELTEARS; GLANDOSANE; HYDROXYCHLOROQUINE SULFATE; HYDROXYPROPYLMETHYLCELLULOSE; ILUBE; IMMUNOMODULATING AGENT; INFLIXIMAB; LACRI LUBE; LUBORANT; LUBRI TEARS; METHOTREXATE; ORALBALANCE; PARAFFIN; PILOCARPINE; POLYVINYL ALCOHOL; RITUXIMAB; SALIVA SUBSTITUTE; STEROID; TEARS NATURALE; UNCLASSIFIED DRUG; VISCOTEARS;

ABDOMINAL PAIN; AUTOIMMUNE DISEASE; CELL DESTRUCTION; CELL FUNCTION; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; DIAGNOSTIC ERROR; DIARRHEA; DISEASE CLASSIFICATION; DRUG SELECTIVITY; DRY EYE; EPITHELIUM CELL; EXOCRINE CELL; EXOCRINE GLAND; FLUSHING; HEADACHE; HUMAN; INFLAMMATION; LIQUIFILM; MEDICAL RESEARCH; MICTURITION DISORDER; MORBIDITY; NAUSEA; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SJOEGREN SYNDROME; SKIN MANIFESTATION; SWEAT GLAND DISEASE; URINARY FREQUENCY;

HUMANS; SJOGREN'S SYNDROME;

EID: 3242718870     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2004.02.010     Document Type: Review

References (48)

1. Manthorpe R. Frost-Larsen K. Isager H. Prause J.U. Sjögren's syndrome: a review with emphasis on immunological features Allergy 36 1981 139-153
2. Ioannidis J.P. Vassiliou V.A. Moutsopoulos H.M. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome Arthritis and Rheumatism 46 2002 741-747
3. Price E.J. Venables P.J. Dry eyes and mouth syndrome-a subgroup of patients presenting with sicca symptoms Rheumatology (Oxford) 41 2002 416-422
4. Fox R.I. Robinson C. Kozin F. Howell F.V. Sjögren's syndrome: proposed criteria for classification Arthritis and Rheumatism 29 1986 577-585
5. Vitali C. Bombardieri S. Moutsopoulos H.M. et al Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community Arthritis and Rheumatism 36 1993 340-348
6. Vitali C. Bombardieri S. Montsopoulos H.M. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European consensus group Annals of the Rheumatic Diseases 61 2002 554-558
7. Thomas E. Hay E.M. Hajeer A. Silman A.J. Sjögren's syndrome: a community-based study of prevalence and impact British Journal of Rheumatology 37 1998 1069-1076
8. Van de Merwe J. Kamerling R. Arendsen E. et al Sjögren's syndrome in patients with interstitial cystitis Journal of Rheumatology 20 1993 962-966
9. Alexander E.L. Malinow K. Lijewski J.E. et al Primary Sjögren's syndrome with central nervous system dysfunction mimicking multiple sclerosis Annals of Internal Medicine 104 1986 323-330
10. Vincent T.L. Richardson M.P. Mackworth-Young C.G. et al. Sjogren's syndrome-associated myelopathy: response to immunosuppressive treatment American Journal of Medicine 114 2003 145-148
11. Skopouli F.N. Moutsopoulos H.M. Autoimmune epitheliitis: Sjogren's syndrome Clinical and Experimental Rheumatology 12 supplement 11 1994 S9-S11
12. Davidson B.K. Kelly C.A. Griffiths I.D. Ten year follow up of pulmonary function in patients with primary Sjogren's syndrome Annals of the Rheumatic Diseases 59 2000 709-712
13. Pease C.T. Shattles W. Charles P.J. et al Clinical, serological and HLA phenotypes subsets in Sjögren's syndrome Clinical and Experimental Rheumatology 17 1989 185-190
14. Goules A. Masouridi S. Tzioufas A.G. et al Clinically significant and biopsy-documented renal involvement in primary Sjögren syndrome Medicine (Baltimore) 79 2000 241-249
15. Bossini N. Savoldi S. Franceschini F. et al Clinical and morphological features of kidney involvement in primary Sjögren's syndrome Nephrology, Dialysis and Transplantation 16 2001 2328-2336
16. Tseng C.E. Buyon J.P. Neonatal lupus syndromes Rheumatic Disease Clinics of North America 23 1997 31-54
17. Kassan S.S. Thomas T.L. Montsopoulos H.M. et al Increased risk of lymphoma in sicca syndrome Annals of Internal Medicine 89 1978 888-892
18. Mulherin D. Ainsworth J.R. Hamburger J. et al Survey of artificial tear and saliva usage among patients with Sjögren's syndrome Annals of the Rheumatic Diseases 60 2001 1077-1078
19. Foster H.E. Gilroy J.J. Kelly C.A. et al The treatment of sicca features in primary Sjögren's syndrome: a clinical review British Journal of Rheumatology 33 1994 278-282
20. Dawson L.J. Smith P.M. Moots R.J. Field E.A. Sjogren's syndrome-time for a new approach Rheumatology (Oxford) 39 2000 234-237
21. Vivino F.B. Al-Hashimi I. Khan Z. et al Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren's syndrome Archives of Internal Medicine 159 1999 174-181
22. Vivino F.B. Salagen ®. The treatment of Sjogren's syndrome with pilocarpine tablets Scandinavian Journal of Rheumatology 115 supplement 2001 1-13
23. Petrone D. Condemi J.J. Fife R. et al A double-blind, randomized, placebo-controlled study of cevimeline in Sjogren's syndrome patients with xerostomia and keratoconjunctivitis sicca Arthritis and Rheumatism 46 2002 748-754
24. Fife R.S. Chase W.F. Dore R.K. et al Cevimeline for the treatment of xerostomia in patients with Sjogren syndrome: a randomized trial Archives of Internal Medicine 162 2002 1293-1300
25. Price E.J. Rigby S.P. Clancy U. Venables P.J. A double blind placebo controlled trial of azathioprine in the treatment of primary Sjogren's syndrome Journal of Rheumatology 25 1998 896-899
26. Fox R.I. Dixon R. Guarrasi V. Krubel S. Treatment of primary Sjõgren's syndrome with hydroxychloroquine; a retrospective, open-label study Lupus 5 1996 31-36
27. Kruize A.A. Hene R.J. Kallenberg C.G. et al Hydroxychloroquine treatment for primary Sjõgren's syndrome; a two year, double blind cross over trial Annals of the Rheumatic Diseases 52 1993 60-64
28. Feldmann M. Maini R.N. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annual Reviews in Immunology 19 2001 163-196
29. Ship J.A. Fox P.C. Michalek J.E. et al Treatment of primary Sjogren's syndrome with low-dose natural human interferon-alpha administered by the oral mucosal route: a phase II clinical trial. IFN Protocol Study Group Journal of Interferon and Cytokine Research 19 1999 943-951
30. Steinfeld S.D. Demols P. Salmon I. et al Infliximab in patients with primary Sjogren's syndrome: a pilot study Arthritis and Rheumatism 44 2001 2371-2375
31. Steinfeld S.D. Demols P. Appelboom T. Infliximab in primary Sjogren's syndrome: one-year follow up Arthritis and Rheumatism 46 2002 3301-3303
32. Somer B.G. Tsai D.E. Downs L. et al American College of Rheumatology ad hoc Committee on Immunologic Testing Guidelines. Improvement in Sjogren's syndrome following therapy with rituximab for marginal zone lymphoma Arthritis and Rheumatism 49 2003 394-398
33. Price E.J. Venables P.J. The aetiopathogenesis of Sjögren's syndome Seminars in Arthritis and Rheumatism 25 1995 117-133
34. Itescu S. Winchester R. Diffuse infiltrative lymphocytosis syndrome: a disorder occurring in human immunodeficiency virus-1 infection that may present as a sicca syndrome Rheumatic Disease Clinics of North America 18 1992 683-697
35. Kordossis T. Paikos S. Aroni K. et al Prevalence of Sjögren's-like syndrome in a cohort of HIV-1-positive patients: descriptive pathology and immunopathology British Journal of Rheumatology 37 1998 691-695
36. Terada K. Katamine S. Eguchi K. et al Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome Lancet 344 1994 1116-1119
37. Garry R.F. Fermin C.D. Hart D. et al Detection of a human intracisternal A-type retroviral particle antigenically related to HIV Science 250 1990 1127-1129
38. Rigby S.P. Griffiths D.J. Weiss R.A. Venables P.J. Human retrovirus-5 proviral DNA is rarely detected in salivary gland biopsy tissues from patients with Sjögren's syndrome Arthritis and Rheumatism 11 1997 2016-2021
39. Green J.E. Hinrichs S.H. Vogel J. Jay G. Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice Nature 341 1989 72-74
40. Hollsberg P. Mechanisms of T-cell activation by human T-cell lymphotropic virus type I Microbiology and Molecular Biology Reviews 63 1999 308-333
41. Harley J.B. Reichlin M. Arnett F.C. et al Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome Science 232 1986 1145-1147
42. Fox R.I. Bumol T. Fantozzi R. et al Expression of histocompatibility antigen HLA DR by salivary epithelial cells in Sjögren's syndrome Arthritis and Rheumatism 29 1985 1105-1111
43. Lindahl G. Hedfors E. Klareskog L. Forsum U. Epithelial HLA-DR expression and T lymphocyte subsets in salivary glands in Sjögren's syndrome Clinical and Experimental Immunology 61 1985 475-482
44. Horsfall A.C. Venables P.J. Allard S.A. Maini R.N. Coexistent anti-La antibodies and rheumatoid factors bear distinct idiotypic markers Scandinavian Journal of Rheumatology 75 supplement 1989 84-88
45. Patel Y.I. McHugh N.J. Apoptosis-new clues to the pathogenesis of Sjögren's syndrome? Rheumatology 39 2000 119-121
46. Fox R.I. Robinson C. Kozin F. Howell F.V. Sjögren's syndrome: proposed criteria for classification Arthritis and Rheumatism 29 1986 577-585
47. Haneji N. Nakamura T. Takio K. et al Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome Science 276 1997 604-607
48. Waterman S.A. Gordon T.P. Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome Arthritis and Rheumatism 43 2000 1647-1654